Sarah H. Kim

1.8k total citations
46 papers, 760 citations indexed

About

Sarah H. Kim is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Sarah H. Kim has authored 46 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Obstetrics and Gynecology, 27 papers in Reproductive Medicine and 8 papers in Surgery. Recurrent topics in Sarah H. Kim's work include Endometrial and Cervical Cancer Treatments (23 papers), Ovarian cancer diagnosis and treatment (22 papers) and Uterine Myomas and Treatments (18 papers). Sarah H. Kim is often cited by papers focused on Endometrial and Cervical Cancer Treatments (23 papers), Ovarian cancer diagnosis and treatment (22 papers) and Uterine Myomas and Treatments (18 papers). Sarah H. Kim collaborates with scholars based in United States, Italy and Brazil. Sarah H. Kim's co-authors include Robert Flaumenhaft, Barbara C. Furie, Reema Jasuja, Bruce Furie, Nawar Latif, Emily Ko, Dimitrios Nasioudis, Robert Giuntoli, Ashley Haggerty and Lin Lin and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Sarah H. Kim

43 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah H. Kim United States 13 247 247 150 125 112 46 760
Qingyu Meng China 18 324 1.3× 76 0.3× 291 1.9× 64 0.5× 121 1.1× 64 899
Lei Deng China 12 74 0.3× 53 0.2× 219 1.5× 34 0.3× 71 0.6× 25 786
Zhijie Xiao China 18 62 0.3× 38 0.2× 569 3.8× 84 0.7× 91 0.8× 37 992
David L. Doering United States 13 128 0.5× 115 0.5× 137 0.9× 8 0.1× 54 0.5× 21 503
Jiaming Huang China 17 100 0.4× 59 0.2× 518 3.5× 21 0.2× 130 1.2× 51 932
Myriam Kossaï France 10 43 0.2× 123 0.5× 277 1.8× 17 0.1× 173 1.5× 36 768
Hisataka Shikama Japan 16 27 0.1× 43 0.2× 327 2.2× 43 0.3× 61 0.5× 28 807
Haiting Mao China 17 53 0.2× 41 0.2× 290 1.9× 23 0.2× 71 0.6× 37 827
Lilach Kleinberg Norway 19 19 0.1× 139 0.6× 521 3.5× 125 1.0× 248 2.2× 27 1.1k
Qiu-Yue Han China 15 38 0.2× 59 0.2× 220 1.5× 19 0.2× 42 0.4× 35 582

Countries citing papers authored by Sarah H. Kim

Since Specialization
Citations

This map shows the geographic impact of Sarah H. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah H. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah H. Kim more than expected).

Fields of papers citing papers by Sarah H. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah H. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah H. Kim. The network helps show where Sarah H. Kim may publish in the future.

Co-authorship network of co-authors of Sarah H. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah H. Kim. A scholar is included among the top collaborators of Sarah H. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah H. Kim. Sarah H. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Minyoung, Emily Ko, Robert Giuntoli, et al.. (2025). Early administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit. International Journal of Gynecological Cancer. 36(2). 102824–102824.
2.
Nasioudis, Dimitrios, Stefan Gysler, Emily Ko, et al.. (2024). Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers. 16(11). 2051–2051. 1 indexed citations
3.
Manning‐Geist, Beryl, Sacha Gnjatic, Carol Aghajanian, et al.. (2023). Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission. Cancers. 15(5). 1458–1458. 12 indexed citations
4.
Nasioudis, Dimitrios, Nawar Latif, Emily Ko, et al.. (2023). Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic Oncology. 177. 14–19. 7 indexed citations
5.
Nasioudis, Dimitrios, Jin-Hee Oh, Emily Ko, et al.. (2022). Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion. International Journal of Gynecological Cancer. 32(9). 1129–1134. 3 indexed citations
6.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2022). Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer. 32(11). 1355–1360. 5 indexed citations
7.
Smith, Anna Jo Bodurtha, Colleen Brensinger, Sarah H. Kim, et al.. (2022). Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study. Gynecologic Oncology Reports. 40. 100922–100922. 11 indexed citations
8.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Nawar Latif, et al.. (2021). Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database. Surgical Oncology. 38. 101589–101589. 11 indexed citations
9.
Nasioudis, Dimitrios, Nawar Latif, Robert Giuntoli, et al.. (2021). Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors. International Journal of Gynecological Cancer. 31(6). 829–834. 17 indexed citations
10.
Nasioudis, Dimitrios, Nawar Latif, Ashley Haggerty, et al.. (2021). Outcomes of comprehensive lymphadenectomy for patients with advanced stage ovarian carcinoma and rare histologic sub-types. International Journal of Gynecological Cancer. 31(8). 1132–1136. 6 indexed citations
11.
Nasioudis, Dimitrios, Maureen Byrne, Emily Ko, et al.. (2021). Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database. International Journal of Gynecological Cancer. 31(8). 1099–1103. 6 indexed citations
12.
Nasioudis, Dimitrios, Benjamin B. Albright, Emily Ko, et al.. (2021). Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis. International Journal of Gynecological Cancer. 31(7). 983–990. 12 indexed citations
13.
Nasioudis, Dimitrios, Maureen Byrne, Emily Ko, et al.. (2021). Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer. International Journal of Gynecological Cancer. 31(12). ijgc–2021. 9 indexed citations
14.
15.
Frey, Melissa K., Sarah H. Kim, Rachelle Chambers, et al.. (2017). Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes. Gynecologic Oncology. 146(1). 123–128. 16 indexed citations
16.
Kim, Sarah H., et al.. (2015). Epithelioid Glomus Tumor of the Uterine Cervix. International Journal of Gynecological Pathology. 35(3). 275–278. 3 indexed citations
17.
Sharda, Anish V., Sarah H. Kim, Reema Jasuja, et al.. (2015). Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome. Blood. 125(10). 1633–1642. 54 indexed citations
18.
Kim, Sarah H., et al.. (2013). Infiltrating gluteal fibrosarcoma presenting as back pain in pregnancy. International Journal of Gynecology & Obstetrics. 123(2). 163–164. 1 indexed citations
19.
Jasuja, Reema, Freda Passam, Daniel R. Kennedy, et al.. (2011). Protein Disulfide Isomerase Inhibitors: A New Class of Antithrombotic Agents. Blood. 118(21). 369–369. 3 indexed citations
20.
Kim, Sarah H., et al.. (2004). Delayed Hemorrhage After Cervical Conization Unmasking Severe Factor XI Deficiency. Obstetrics and Gynecology. 104(5). 1189–1192. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingyu Meng Breakdown of academic impact, for papers by Lei Deng Breakdown of academic impact, for papers by Zhijie Xiao Breakdown of academic impact, for papers by David L. Doering Breakdown of academic impact, for papers by Jiaming Huang Breakdown of academic impact, for papers by Myriam Kossaï Breakdown of academic impact, for papers by Hisataka Shikama Breakdown of academic impact, for papers by Haiting Mao Breakdown of academic impact, for papers by Lilach Kleinberg Breakdown of academic impact, for papers by Qiu-Yue Han
Rankless by CCL
2026